Donald Bergstrom
2020
In 2020, Donald Bergstrom earned a total compensation of $2M as Executive Vice President, Head of Research & Development at Relay Therapeutics, a 119% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,000 |
|---|---|
| Option Awards | $1,339,104 |
| Salary | $440,000 |
| Other | $9,816 |
| Total | $2,008,920 |
Bergstrom received $1.3M in option awards, accounting for 67% of the total pay in 2020.
Bergstrom also received $220K in non-equity incentive plan, $440K in salary and $9.8K in other compensation.
Rankings
In 2020, Donald Bergstrom's compensation ranked 5,492nd out of 13,090 executives tracked by ExecPay. In other words, Bergstrom earned more than 58.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,492 out of 13,090 | 58th |
Division Manufacturing | 2,260 out of 5,624 | 60th |
Major group Chemicals And Allied Products | 903 out of 2,257 | 60th |
Industry group Drugs | 780 out of 1,957 | 60th |
Industry Biological Products, Except Diagnostic Substances | 188 out of 411 | 54th |
Source: SEC filing on April 7, 2021.
Bergstrom's colleagues
We found two more compensation records of executives who worked with Donald Bergstrom at Relay Therapeutics in 2020.